AI is fundamentally dependent on data, but the vast majority of health data goes unused for understandable reasons — chiefly patient privacy, regulation, and IP protection. “This is the core underlying problem” of building AI solutions for life sciences and related areas like pharmaceutics, said German entrepreneur Robin Röhm.